AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $394,000 | -8.8% | 9,525 | -16.7% | 0.00% | 0.0% |
| Q4 2021 | $432,000 | +14.6% | 11,440 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $377,000 | -25.8% | 11,440 | +51.8% | 0.00% | 0.0% |
| Q2 2021 | $508,000 | -7.0% | 7,535 | -21.9% | 0.00% | -33.3% |
| Q1 2021 | $546,000 | +103.0% | 9,650 | +270.7% | 0.00% | +50.0% |
| Q4 2019 | $269,000 | +24.5% | 2,603 | -75.6% | 0.00% | 0.0% |
| Q3 2019 | $216,000 | -23.1% | 10,675 | -2.1% | 0.00% | -33.3% |
| Q2 2019 | $281,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
| MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
| Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
| WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
| MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
| RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
| MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
| Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
| FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |